Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Big picture initiatives in bleeding disordersAntoine Rauch, Leonard A Valentino, Kevin Mills, et al.
Thrombosis Research|August 5, 2021
Novel missense mutations affecting the structure of the conserved fibrinogen Bβ C-terminal domain cause congenital hypofibrinogenemiaRaquel Bártolo, Maxime Arbez, Rui Vilar, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2016
Abacavir has no prothrombotic effect on platelets in vitroYacouba L Diallo, Véronique Ollivier, Véronique Joly, et al.
Thrombosis and Haemostasis|July 18, 2014
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devicesAntoine Rauch, Paulette Legendre, Olivier D Christophe, et al.
Blood Advances|July 9, 2021
Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia BBeatrice Nolan, Anna Klukowska, Amy Shapiro, et al.
JACC. Basic to Translational Science|December 14, 2023
Negative Impact of <i>TET2</i> Mutations on Long-Term Survival After Transcatheter Aortic Valve ReplacementFanny Lassalle, Nicolas Duployez, Flavien Vincent, et al.
JACC. Cardiovascular Interventions|September 8, 2018
Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of Mini-Invasive Transcatheter Aortic Valve Replacement?Flavien Vincent, Antoine Rauch, Hugues Spillemaeker, et al.
Blood Advances|October 21, 2025
Modeling Response to High-Purity Von Willebrand Factor: Toward Tailored Dosing During Surgery in von Willebrand DiseaseMelanie Y Daniel, Antoine Rauch, Camille Paris, et al.
Acta Diabetologica|March 19, 2017
Leptin induces osteoblast differentiation of human valvular interstitial cells via the Akt and ERK pathwaysMickael Rosa, Camille Paris, Yoann Sottejeau, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 12, 2019
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra<sup>®</sup> ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP)Sophie Susen, Yves Gruel, Anne Godier, et al.
Pageof 6